Preview

Russian neurological journal

Advanced search

Neurosarcoidosis

https://doi.org/10.30629/2658-7947-2020-25-5-45-50

Abstract

The article represents the discussion of sarcoidosis involving the cranial nerves and meninges. It’s a rare disease dicult to diagnose. This form of the disease is a progressive lesion of the nervous system, characterized by granulomatous inflammation of the membranes and /or tissue of cerebrum or spinal cord, cranial and /or peripheral nerves. Clinical signs of the nervous system disorder found in sarcoidosis, are detected only in 5–15% of patients. They are often represented by symptoms of cranial nerve damage, meningeal syndrome and epileptic seizures. X-ray computed tomography and magnetic resonance imaging of the brain do not reveal specific changes, however, they allow to exclude other structural lesions of the central nervous system and to identify neuroimaging signs, most common in the course of this disease. Diagnosis of neurosarcoidosis is possible in the presence of neurological symptoms, signs of multisystem lesions, and histological confirmation of non-caseous granulomatous inflammation in one or more organs. The article also represents a clinical observation of a patient with neurosarcoidosis, manifested by acute bilateral neuropathy of the facial nerves, unilateral neuropathy of the trigeminal nerve and meningism syndrome. The neuroimaging signs, often found in this disease, were revealed: the accumulation of contrast agent by the membranes of the brain and the tissue of cavum Meckeli. The course of the disease and diagnostic search, which made it possible to detect signs of multisystem lesion, are described. The diagnosis was confirmed by histological examination of the biopsy material of the intrathoracic lymph node. The results of neurosarcoidosis anti-inflammatory therapy are presented. The peculiarities influencing the choice of this type of treatment terms, are indicated.

About the Authors

G. R. Ramazanov
Государственное бюджетное учреждение здравоохранения «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского» Департамента здравоохранения г. Москвы
Russian Federation


E. V. Shevchenko
State Budgetary Health Institution of Moscow «Research Institute of Emergency Care named after N.V. Sklifosovsky Moscow Board of Health»
Russian Federation
Moscow


L. I. Idilova
State Budgetary Health Institution of Moscow «Research Institute of Emergency Care named after N.V. Sklifosovsky Moscow Board of Health»
Russian Federation
Moscow


V. N. Stepanov
State Budgetary Health Institution of Moscow «Research Institute of Emergency Care named after N.V. Sklifosovsky Moscow Board of Health»
Russian Federation
Moscow


E. V. Nugaeva
State Budgetary Health Institution of Moscow «Research Institute of Emergency Care named after N.V. Sklifosovsky Moscow Board of Health»
Russian Federation
Moscow


S. S. Petrikov
State Budgetary Health Institution of Moscow «Research Institute of Emergency Care named after N.V. Sklifosovsky Moscow Board of Health»
Russian Federation
Moscow


References

1. Suslina Z.A., Kistenev B.A., Maksimova M.Yu., Morgunov V.A. Nejrosarkoidoz. M.; MEDpress-inform; 2009:208. (In Russian).

2. Mozolevskij Yu.V., Ahmedzhanova L.T., Suslova E.Yu., Yahno N.N. Izolirovannyj nejrosarkoidoz. Nevrologicheskij zhurnal. 2013;(6):33–39 (In Russian).

3. Lacomis D. Neurosarcoidosis. Curr. Neuropharmacol. 2011;9(3):429–436. https://doi.org/10.2174/157015911796557975

4. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., du Bois R. et al. Statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 1999;160(2):736–755. https://doi.org/10.1164/ajrccm.160.2.ats4-99

5. Ungprasert P., Ryu J.H., Matteson E.L. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin. Proc. Innov. Qual. Outcomes. 2019;3(3):358–375. https://doi.org/10.1016/j.mayocpiqo.2019.04.006

6. Zajicek J., Scolding N., Foster O., Rovaris M., Evanson J., Moseley I.F. et al. Central nervous system sarcoidosis-diagnosis and management. Quart. J. Med. 1999;92(2):103–117. https://doi.org/10.1093/qjmed/92.2.103

7. Judson M.A. Extrapulmonary sarcoidosis. Semin. Respir. Crit. Care Med. 2007;28(1):83–101. https://doi.org/10.1055/s-2007-970335

8. Galassi G., Gibertoni M., Mancini A., Nemni R., Volpi G., Merelli E. et al. Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases. Eur. Neurol. 1984;23(6):459–465. https://doi.org/10.1159/000115728

9. Lacomis D. Neurosarcoidosis. Curr. Neuropharmacol. 2011;9(3):429–436. https://doi.org/10.2174/157015911796557975

10. Varol S., Ozdemir H.H., Akil E., Arslan D., Aluclu U.M., Caner F. et al. Facial diplegia: etiology, clinical manifestations, and diagnostic evaluation. Arq. Neuropsiquiatr. 2015;73(12):998– 1001. https://doi.org/10.1590/0004-282X20150174

11. Drent M., Costabel U. Sarcoidosis. Monography ERS, 2005;32. https://doi.org/10.1183/1025448x.erm3205

12. Stern B.J., Royal W. 3rd, Gelfand J.M. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75(12):1546–1553. https://doi.org/10.1001/jamaneurol.2018.2295

13. Smith J.K., Matheus M.G., Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am. J. Roentgenol. 2004;182(2):289– 295. https://doi.org/10.2214/ajr.182.2.1820289

14. Braksick S., Shah-Haque S., El-Haddad B., Moussa R. Neurosarcoidosis Presenting as Trigeminal Nevralgia: A Case Report and Review of the Literature. Sarcoidosis Vasc. Diffuse Lung. Dis. 2013;30(2):153–156. PMID: 24071889.

15. Martin-Duverneuil N., Teichmann M., De Broucker T. Simultaneous bilateral paralysis of cranial nerves V and VI unmasking neurosarcoidosis: symmetrical involvement of Meckel’s cave. Rev Neurol (Paris). 2001;157(12):1575–1578. PMID: 11924460.

16. Bridel C., Courvoisier D.S., Vuilleumier N. Cerebrospinal fluid angiotensin-converting enzyme for diagnoses of neurosarcoidosis. J. Neuroimmunol. 2015;285:1–3. https://doi.org/10.1016/j.jneuroim.2015.05.020

17. Ungprasert P., Carmona E.M., Crowson C.S., Matteso E.L. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung. 2016;194(1):91–95. https://doi.org/10.1007/s00408-015-9826-3

18. Barrantes-Freer A., Engel A.S., Rodríguez-Villagra O.A. Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination. Brain Pathol. 2018;28(2):225–233. https://doi.org/10.1111/bpa.12496

19. Hebel R., Dubaniewicz-Wybieralska M., Dubaniewicz A. Overview of neurosarcoidosis: recent advances. J. Neurol. 2015;262(2):258–267. https://doi.org/10.1007/s00415-0147482-9


Review

For citations:


Ramazanov G.R., Shevchenko E.V., Idilova L.I., Stepanov V.N., Nugaeva E.V., Petrikov S.S. Neurosarcoidosis. Russian neurological journal. 2020;25(5):45-50. (In Russ.) https://doi.org/10.30629/2658-7947-2020-25-5-45-50

Views: 3417


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2658-7947 (Print)
ISSN 2686-7192 (Online)